# Presymptom Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/presymptom-health

- Industry: Medical Devices & Equipment
- Headquarters: Leeds, UK
- Website: www.presymptom.com/
- Latest round: Seed (Mar 21, 2024)
- Investors on record: 3

## About

Founded in 2019 and based in Leeds, UK, Presymptom Health Limited provides tests for the pre-symptomatic diagnosis of sepsis.  As of 2024, the company is headed by its CEO Dr Iain Miller. In February 2025, Presymptom Health Limited received GBP 200,000 in grant funding from the Small Business Research Initiative and Department for Health and Social Care. The firm engages itself in the development of clinical diagnostic tests and associated clinical decision-support software that helps in the detection of infection and sepsis. The test developed by the firm runs on molecular PCR genomic systems.

The company will use the February 2025 grant funding to accelerate the development of its AI-driven infection detection technology and make its rapid tests compatible with widely available PCR machines.

## Funding rounds

- Seed, Mar 21, 2024 — Future Planet Capital, Medtech To Market Ltd, Ploughshare Innovations Limited

## Investors

- Future Planet Capital (https://capitalatlas.ai/funds/future-planet-capital) — Seed
- Medtech To Market Ltd — Seed
- Ploughshare Innovations Limited — Seed